Stanley-Laman Group, Ltd. - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 21 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Stanley-Laman Group, Ltd. ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q1 2016$68,000
-82.7%
11,269
-84.7%
0.01%
-80.6%
Q4 2015$394,000
+18.7%
73,862
-10.2%
0.07%
-1.5%
Q3 2015$332,000
-61.5%
82,259
-53.2%
0.07%
-57.0%
Q2 2015$863,000
-13.9%
175,820
-29.1%
0.16%
-13.7%
Q1 2015$1,002,000
-5.9%
247,956
-8.9%
0.18%
-9.4%
Q4 2014$1,065,000
+5.1%
272,2870.0%0.20%
+2.5%
Q3 2014$1,013,000
-4.4%
272,287
-11.9%
0.20%
+1.0%
Q2 2014$1,060,000
-3.5%
308,919
-3.1%
0.20%
+1.6%
Q1 2014$1,099,000
+386.3%
318,681
+374.6%
0.19%
+291.8%
Q4 2013$226,00067,1430.05%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,030,533$22,539,0004.01%
ARS Investment Partners, LLC 796,367$8,840,0001.41%
Gagnon Advisors, LLC 194,579$2,160,0001.37%
GAGNON SECURITIES LLC 263,894$2,929,0000.84%
Benchmark Capital Advisors 96,235$1,068,0000.81%
PERKINS CAPITAL MANAGEMENT INC 94,550$1,050,0000.75%
Cortina Asset Management, LLC 645,718$7,167,0000.34%
EAM Investors, LLC 73,327$814,0000.13%
Whitegate Investment Counselors, Inc. 11,000$122,0000.02%
ROYCE & ASSOCIATES LP 299,353$3,323,0000.02%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders